What adverse effect is linked to Halothane administration?

• A. Adrenal insufficiency
• B. Hepatotoxicity leading to acute liver failure
• C. Severe hypotension
• D. Hyperkalemia

Answer: (B)

Halothane, a volatile anesthetic agent, is known for its potential to cause hepatotoxicity, which can lead to acute liver failure in some individuals. This adverse effect is due to a combination of metabolic processes and immune responses that can result in liver cell damage. When Halothane is metabolized by the liver, it can generate trifluoroacetylated metabolites that may provoke an immune-mediated response in susceptible individuals, leading to necrosis or severe liver injury.

Furthermore, cases of Fulminant hepatic failure have been documented following exposure to Halothane, which aligns with its classification as a hepatotoxic agent. Monitoring liver function before and after the use of Halothane is essential, especially in patients with pre-existing liver conditions or those who have had multiple exposures to this anesthetic.

While other choices present serious conditions, they are not directly attributable to Halothane in terms of established adverse drug reactions. Adrenal insufficiency, severe hypotension, and hyperkalemia can occur in various clinical settings or with different anesthetic agents, but they do not have a well-documented association with Halothane specifically.